Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 24 minutes agoBut the competitor vaccines have full FDA approval. Meanwhile, Novavax's shot has been available in...
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 5 hours agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
Reuters via Yahoo News· 6 days agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a...
Charles River and Sanofi collab to replace animals with virtual controls in preclinical research
FierceBiotech· 2 days agoCharles River Laboratories and Sanofi are working on a new project in which virtual control animals...
A salty diet may increase eczema in adults, study finds
Washington Post· 22 hours agoAdults who eat a salty diet appear to have a higher risk for eczema, according to a study by...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 1 day agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 21 hours agoNovavax is also benefiting from investments from Sanofi (SNY), as the French pharma giant looks to license Novavax's platform and has taken a minority...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 3 days agoPfizer, Boehringer Ingelheim, Sanofi, and Patheon are also implicated in the cases. In 2020, the US Food and Drug Administration (FDA) ordered the...
Data needed to forge the link between AI and mRNA
Pharmaceutical Technology via Yahoo Finance· 1 day agoAgainst this backdrop, several deals are pushing forth investments in both mRNA and AI. In 2021, Sanofi acquired the mRNA tech company Translate Bio,...
Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 day agoThe phase IIa study will be initiated in 2024. Biogen is conducting the ongoing global phase IIb...
